Presenter
Farshad Forouzandeh, M.D., Ph.D., FSCAI, University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH
Farshad Forouzandeh, M.D., Ph.D., FSCAI, University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH
Learning Objectives:
- Review current guidelines and best practices for anti-platelet and anti-thrombotic agents used in STEMI
- Discuss the role of thrombolytics (systemic) when PCI is not available and the role of intra-coronary thrombolytics for heavy thrombus burden
- Discuss the role of periprocedural IV anti-platelet agents and the optimal choice and duration of oral anti-platelet agents
Keywords: Acute Coronary Syndromes (ACS)